Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 24 Apr 2023
According to a recent study, bariatric surgery reduced incident cardiovascular disease and composite cardiovascular adverse outcomes by almost 50%.
Read Full NewsA nurse practitioner at the Rocky Mountain MS Clinic discussed emerging therapeutics, evolving management strategies, and unmet needs in multiple sclerosis, specifically in women’s health.
The FDA has granted priority review to Takeda’s new drug application for oveporexton, an orexin receptor 2-selective agonist, for narcolepsy type 1, with a PDUFA date in the third quarter of 2026.
Paul Nghiem highlights several key takeaways from his talk on cutaneous oncology, touching on various advances in skin cancer management.
REZOLVE-AD: Rezpegaldesleukin Improves Symptoms of Atopic Dermatitis
1.
FDA Approves New Bladder Cancer First-Line Standard of Care.
2.
Pickleball program boosts health and wellness for cancer survivors, study finds
3.
Recent research suggests that vitamin supplements may increase the risk of developing cancer.
4.
WHO releases new R&D landscape analyses highlighting gaps and inequities in cancer research
5.
Big Drop in Cervical Cancer Deaths; Publication Hijackers; A Win for CRC Home Tests
1.
Understanding Leiomyoma: Causes, Symptoms, and Treatment Options
2.
Skin-Sparing Mastectomy: Balancing Cancer Control with Cosmetic Results
3.
Subarachnoid Hemorrhage: Emerging Insights into Pathophysiology and Future Management
4.
Liquid Biopsy: A Game-Changer in T-Cell Lymphoma Detection and Management
5.
Exploring the Mysteries of MGUS: Uncovering the Causes and Treatments
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Preventing Blood Clots: The Importance of Venous Thromboembolism Management
2.
Daratumumab, Lenalidomide, and Dexamethasone (DRd) Versus Lenalidomide and Dexamethasone (Rd) in MRD Negativity
3.
An In-Depth Look At The Signs And Symptoms Of Lymphoma- Further Discussion
4.
Current Scenario of Cancer- Final Discussion on the Importance of Genomic Testing & Advancement in Diagnosis and Treatment
5.
Updates on the First Line Management of ALK+ NSCLC
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge